Vivo is firmly in the same smartphone sales tier as companies like Oppo and Xiaomi, but it has pursued a low-key IP strategy very different to that of its chief rivals
SiOnyx, which is owned by the investment giant, and co-plaintiff Harvard accuses Japanese optical devices manufacturer of patent infringement
Lack of IP funds and staff at Kyoto University may have left immunotherapy pioneer Tasuku Honjo with a poor deal in agreement with Ono Pharmaceutical.
Recent assignments showcase different ways Huawei reaps value from patent deals: one sealing its settlement with Samsung, another arming America’s most prolific NPE
“We’ve used them as a litigation firm in the past, they know our portfolio really well and we wanted to take the opportunity to leverage that expertise more broadly to focus it on co-developing licensing programmes along with our own team,” says Invention Investment Fund head Mathen Ganesan
In an interview with IAM, firm president Joe Siino (pictured, far right) also confirms expansion of operations in Hong Kong, with former Technicolor licensing head Deirdre Leane soon to join the team
Senior exec at ride-sharing leader reveals how his role has changed, how he has handled the transition from in-house to private practice and back and how he thinks IP strategy is set to evolve.
The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals
No free passes insists Excalibur head as he contemplates future of $250m portfolio after parent company announces dissolution
With so many issues emerging across the entire supply chain, the sector’s IP leaders will be sharing their thoughts and insights at events in Detroit and Munich next month
How boards of directors can better understand the leading source of a company’s value.
As the fourth industrial revolution gets underway, operating companies need to ensure that their IP strategies are fit for a rapidly changing technological landscape.
"The business places more and more scrutiny on patent spend, and asks the patent team to quantify the value proposition and return on investment,” says David Dutcher
The IAM/ktMINE US Patent 100 countdown today reaches the top 20 entities and reveals that the Korean conglomerate holds over 25,000 more active USPTO-granted assets than second-placed IBM
Former RPX chief tight-lipped on new venture, but details start to emerge of IP legal services play